Concepedia

Sterling R. Putt

SR

Statistics

Publications

12

Citations

373

H-Index

11

Active since

1978

Affiliations

Pfizer (United States)(Current)

Sterling R. Putt is an author at Pfizer (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1978–2006

12

Publications

12

Total synthesis of (8R)-3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol (pentostatin), the potent inhibitor of adenosine deaminase

Eunice Chan, Sterling R. Putt, H. D. Hollis Showalter et al. · The Journal of Organic Chemistry · 1982 · 61 citations

, , +6

<i>C</i>-Acylation of Nitromethane. A Synthetic Route to α-Nitroketones

David C. Baker, Sterling R. Putt · Synthesis · 1978 · 51 citations

, , +5

Prodrugs of 9-(.beta.-D-arabinofuranosyl)adenine. 2. Synthesis and evaluation of a number of 2',3'- and 3',5'-di-O-acyl derivatives

David C. Baker, Theodore H. Haskell, Sterling R. Putt et al. · Journal of Medicinal Chemistry · 1979 · 41 citations

, , +12

A total synthesis of pentostatin, the potent inhibitor of adenosine deaminase

David C. Baker, Sterling R. Putt · Journal of the American Chemical Society · 1979 · 40 citations

, , +9

Synthesis of the dipeptide hydroxyethylene isostere of Leu-Val, a transition state mimic for the control of enzyme function

Peter G. M. Wuts, Sterling R. Putt, Allen R. Ritter · The Journal of Organic Chemistry · 1988 · 38 citations

, , +12

1–5 of 12